Clinical trials
Completed Clostridium Infections trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
70 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 3 |
| 2006 | 2 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 3 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 6 |
| 2014 | 4 |
| 2015 | 3 |
| 2016 | 6 |
| 2017 | 10 |
| 2018 | 6 |
| 2019 | 10 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 70 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 4 |
| Rebiotix Inc. | 4 |
| Seres Therapeutics, Inc. | 3 |
| Summit Therapeutics | 3 |
| University of Wisconsin, Madison | 3 |
| AstraZeneca | 2 |
| Brigham and Women's Hospital | 2 |
| Finch Research and Development LLC. | 2 |
| Massachusetts General Hospital | 2 |
| Medical College of Wisconsin | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Clostridium Infections | 70 |
| Diarrhea | 15 |
| Enterocolitis, Pseudomembranous | 5 |
| Communicable Diseases | 3 |
| Bacterial Infections | 2 |
| Colitis, Ulcerative | 2 |
| Cross Infection | 2 |
| Diabetes Insipidus, Neurogenic | 2 |
| Gastrointestinal Diseases | 2 |
| Inflammatory Bowel Diseases | 2 |
Trials
Showing 1 to 25 of 70. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.